Logo image of MRZ.CA

MIRASOL RESOURCES LTD (MRZ.CA) Stock Fundamental Analysis

TSX-V:MRZ - TSX Venture Exchange - CA6046801081 - Common Stock - Currency: CAD

0.4  +0.01 (+1.27%)

Fundamental Rating

2

Taking everything into account, MRZ scores 2 out of 10 in our fundamental rating. MRZ was compared to 822 industry peers in the Metals & Mining industry. While MRZ has a great health rating, there are worries on its profitability. MRZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year MRZ has reported negative net income.
MRZ had a negative operating cash flow in the past year.
MRZ had negative earnings in each of the past 5 years.
In the past 5 years MRZ always reported negative operating cash flow.
MRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFMRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

MRZ's Return On Assets of -179.44% is on the low side compared to the rest of the industry. MRZ is outperformed by 78.30% of its industry peers.
MRZ has a worse Return On Equity (-204.35%) than 70.67% of its industry peers.
Industry RankSector Rank
ROA -179.44%
ROE -204.35%
ROIC N/A
ROA(3y)-121.06%
ROA(5y)-87.62%
ROE(3y)-137.49%
ROE(5y)-98.57%
ROIC(3y)N/A
ROIC(5y)N/A
MRZ.CA Yearly ROA, ROE, ROICMRZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MRZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MRZ.CA Yearly Profit, Operating, Gross MarginsMRZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, MRZ has more shares outstanding
Compared to 5 years ago, MRZ has more shares outstanding
MRZ has a worse debt/assets ratio than last year.
MRZ.CA Yearly Shares OutstandingMRZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MRZ.CA Yearly Total Debt VS Total AssetsMRZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 7.68 indicates that MRZ is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 7.68, MRZ is doing good in the industry, outperforming 73.58% of the companies in the same industry.
There is no outstanding debt for MRZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.68
ROIC/WACCN/A
WACCN/A
MRZ.CA Yearly LT Debt VS Equity VS FCFMRZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 5.50 indicates that MRZ has no problem at all paying its short term obligations.
MRZ's Current ratio of 5.50 is fine compared to the rest of the industry. MRZ outperforms 79.27% of its industry peers.
MRZ has a Quick Ratio of 5.50. This indicates that MRZ is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MRZ (5.50) is better than 79.52% of its industry peers.
Industry RankSector Rank
Current Ratio 5.5
Quick Ratio 5.5
MRZ.CA Yearly Current Assets VS Current LiabilitesMRZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.20% over the past year.
EPS 1Y (TTM)29.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRZ.CA Yearly Revenue VS EstimatesMRZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
MRZ.CA Yearly EPS VS EstimatesMRZ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

MRZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRZ.CA Price Earnings VS Forward Price EarningsMRZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRZ.CA Per share dataMRZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MRZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MIRASOL RESOURCES LTD

TSX-V:MRZ (3/7/2025, 7:00:00 PM)

0.4

+0.01 (+1.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)02-24 2022-02-24
Inst Owners10.67%
Inst Owner ChangeN/A
Ins Owners34.82%
Ins Owner ChangeN/A
Market Cap32.44M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.49
P/tB 7.49
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -179.44%
ROE -204.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-121.06%
ROA(5y)-87.62%
ROE(3y)-137.49%
ROE(5y)-98.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 122.09%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.5
Quick Ratio 5.5
Altman-Z 7.68
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)102.57%
Cap/Depr(5y)113.08%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.58%
OCF growth 3YN/A
OCF growth 5YN/A